Search

everythinglearnresearchcommunity

for

Search:↓

Bolandiol, a synthetic steroid, builds muscle and bone without greatly affecting sex glands, and works differently from other hormones.

Ritlecitinib improves hair regrowth satisfaction in alopecia areata patients.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

Leonuri Herba alkaloids may help treat hormone-induced enlarged prostate in rats.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Low-dose Ritlecitinib may help children with stubborn Alopecia Areata.

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.

Monoolein-alginate beads help heal wounds by controlling moisture and effectively delivering adenosine to the skin.

Elental is a good long-term treatment for Crohn's disease, similar to 6-mercaptopurine but with fewer side effects.

A woman's hair loss was probably caused by the antifungal drug anidulafungin.

Ritlecitinib is an effective new treatment for Alopecia Areata.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Enzalutamide, a prostate cancer drug, may help prevent COVID-19 by blocking the virus from entering lung cells.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Letrozole may help prevent seizures by reducing certain hormone levels.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Busulfan/cyclophosphamide and total bone irradiation are equally effective for AML transplants.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.